Information about Amador Bioscience
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0779.966.013

VAT liability
Yes
Established
11-01-2022
Last balance sheet year
2023
Company size
Small 8,6 FTE
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from Amador Bioscience

2023 2022
Profit/Loss -1,164,701 -84 % -632,406
Equity -1,697,106 -219 % -532,406
Gross margin -355,449 -118 % -162,734
Employees 8.6 4.7

Publications from Amador Bioscience

Date Publication
24-10-2025 Resignations - Appointments (NL)
22-01-2025 Registered Office (NL)
08-07-2022 Resignations - Appointments (NL)
13-01-2022 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Amador Bioscience?
The VAT number of Amador Bioscience is BE 0779.966.013.
Wat is the PEPPOL ID of Amador Bioscience?
There is no information available about the PEPPOL ID of Amador Bioscience or the company is not yet registered on the PEPPOL network.
When was Amador Bioscience founded?
Amador Bioscience was founded on 11-01-2022.
What is the address of Amador Bioscience?
The current registered office of Amador Bioscience is located at Hendrik van Veldekesingel 150/61, 3500 Hasselt.
When was the last time Amador Bioscience filed their annual financial statements?
The most recent financial statements of Amador Bioscience were filed on 02-10-2024.
How many employees does Amador Bioscience have?
There are 8,6 FTEs working at Amador Bioscience according to the staff figures in the most recent financial statements.
What is the annual turnover of Amador Bioscience?
At the time of its most recent financial statements, Amador Bioscience did not publish any turnover figures. Amador Bioscience reported a gross margin of -€355,448.97.